| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/03/1996 | EP0719267A1 Second messenger cell signaling inhibitors |
| 07/03/1996 | EP0719251A1 Bicyclo (2.2.2) octane derivatives cholecystokinin and/or gastrin antagonists |
| 07/03/1996 | EP0719150A1 Cellular vaccine and methods of use for the treatment of solid tumor malignancies |
| 07/03/1996 | EP0719147A1 Gene therapy for solid tumors, papillomas and warts |
| 07/03/1996 | EP0719144A1 Trans platinum(iv) complexes |
| 07/03/1996 | EP0669836B1 Therapeutic application of chimeric and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen for treatment of b cell lymphoma |
| 07/03/1996 | CN1125947A Carbo-acyclic nucleoside derivatives as antiviral and antineoplastic agents |
| 07/03/1996 | CN1125944A Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 07/03/1996 | CN1125943A Bis-imide polycyclic and heterocyclic chromophores useful as tumoricidals |
| 07/03/1996 | CN1125942A Substituted beta-aryl and beta-heteroaryl-alpha-cyanoacrylamide derivatives as tyrosine kinase inhibitors |
| 07/03/1996 | CN1125941A Novel vitamin D analogues |
| 07/03/1996 | CN1125722A Ortho-substituted benzoic acid derivatives |
| 07/03/1996 | CN1125575A Adhesion receptor antagonists |
| 07/03/1996 | CN1032204C Process for preparing acetylenes disubstituted with phenyl group and heterobicyclic group having retinoid like activity |
| 07/02/1996 | US5532388 Preparation of antitumor agents |
| 07/02/1996 | US5532363 Heteroaryl substituted oxazinone compounds for the preparation of taxol |
| 07/02/1996 | US5532359 Fungicides |
| 07/02/1996 | US5532337 Proteins comprising calmodulin- and actin-binding human caldesmon polypeptide fragments |
| 07/02/1996 | US5532263 Benzothiopyranoindazole antitumor agents |
| 07/02/1996 | US5532259 Isoxazole-4-carboxamides and hydroxyalkylidenecyanoacetamides, pharmaceuticals containing these compounds and their use |
| 07/02/1996 | US5532255 Anticoagulants, cardiovascular disorders, antiinflammatory agents, arteriosclerosis or antitumor agents |
| 07/02/1996 | US5532232 Inhibit thrombin induced platelet aggregation; fibrinogen anticoagulants in blood |
| 07/02/1996 | US5532218 Antitumor agents |
| 07/02/1996 | US5532159 Antitumor agents; hybridomas |
| 07/02/1996 | CA1338432C Esters of 3-demethylthiocolchicine and n-acyl analogs |
| 06/27/1996 | WO1996019583A1 Recombinant proteinase from clostridium hystolyticum and the use thereof for isolating cells and cell groups |
| 06/27/1996 | WO1996019580A2 Telomerase protein component |
| 06/27/1996 | WO1996019579A1 Nuclear protein serine/threonine kinases |
| 06/27/1996 | WO1996019499A2 Improved cyclic crf antagonists |
| 06/27/1996 | WO1996019494A1 Peptides having immunomodulatory activity |
| 06/27/1996 | WO1996019473A1 New derivatives of pyroglutaminic acid, preparation process and applications |
| 06/27/1996 | WO1996019230A1 Soluble 2-chloro-2'-deoxyadenosine formulations |
| 06/27/1996 | WO1996019229A1 Stable solutions of 2-chloro-2'-deoxyadenosine formulations |
| 06/27/1996 | WO1996019226A1 Combination chemotherapy of suramin and a vinca-alkaloid or estramustine |
| 06/27/1996 | WO1996019212A1 Use of boswellic acid for treating brain tumours |
| 06/27/1996 | WO1996019209A1 Chalcones and esters thereof with antiproliferative activity in uterus, ovary and breast tumours |
| 06/27/1996 | DE4445891A1 Rekombinante Proteinase aus Clostridium histolyticum und ihre Verwendung zur Isolierung von Zellen und Zellverbänden Recombinant proteinase from Clostridium histolyticum and their use for the isolation of cells and cell aggregates |
| 06/27/1996 | DE4445728A1 Verwendung von Boswelliasäure zur Behandlung von Hirntumoren Use of boswellic acid for the treatment of brain tumors |
| 06/27/1996 | DE19547958A1 Anthracyclin-Derivate Anthracycline derivatives |
| 06/27/1996 | CA2208324A1 Recombinant proteinase from clostridium hystolyticum and the use thereof for isolating cells and cell groups |
| 06/27/1996 | CA2206778A1 Peptides having immunomodulatory activity |
| 06/27/1996 | CA2206112A1 Combination chemotherapy of suramin and a vinca-alkaloid or estramustine |
| 06/27/1996 | CA2206059A1 Improved cyclic crf antagonists |
| 06/27/1996 | CA2165895A1 Platinum complex and malignant tumor treating drug containing the same |
| 06/26/1996 | EP0718287A2 Piperazine derivatives, medicaments containing them, their use, and processes for their preparation |
| 06/26/1996 | EP0718286A1 3-Alkoxybenzylpiperidine derivatives as melatonergic agents |
| 06/26/1996 | EP0718285A2 Restricted 9-cis-retinoids |
| 06/26/1996 | EP0717994A1 New formulation for the topical treatment of psoriasis |
| 06/26/1996 | EP0717750A1 Double-stranded peptide nucleic acids |
| 06/26/1996 | EP0717633A1 Growth differentiation factor-7 |
| 06/26/1996 | EP0717631A1 Immunomodulating compositions from bile |
| 06/26/1996 | CN1125479A Ligands for FLT3 receptors |
| 06/26/1996 | CN1125444A Antiproliferative naphthyridines |
| 06/26/1996 | CN1125436A Vitamin D amide derivatives |
| 06/25/1996 | US5530128 Enzyme inhibitor as antitumor agent |
| 06/25/1996 | US5530109 DNA encoding glial mitogenic factors |
| 06/25/1996 | US5530101 Humanized immunoglobulins |
| 06/25/1996 | US5530097 Human cancer inhibitory peptide amides |
| 06/25/1996 | US5530095 Skin disorders, antitumor agents |
| 06/25/1996 | US5530020 Taxol derivatives |
| 06/25/1996 | US5530012 3-alkoxybenzylpiperidine derivatives as melatonergic agents |
| 06/25/1996 | US5529999 Antitumor compositions and methods of treatment |
| 06/25/1996 | US5529922 Anti-idiotypic monoclonal antibody that induces an immune response against the ganglioside GD3 and hybridoma producing said antibody |
| 06/25/1996 | US5529903 Extraction and cultivation of transformed cells and production of antibodies directed against them |
| 06/25/1996 | US5529792 Homogenizing chicken embryo or adult bovine brain tissue, centrifuging, applying to cation exchanger, separating active fractions by gel filtration chromatography, purifying by reverse phase liquid chromatography |
| 06/25/1996 | US5529774 In vivo transfer of the HSV-TK gene implanted retroviral producer cells |
| 06/24/1996 | CA2165922A1 Piperazine derivatives, medicaments comprising these compounds, their use and processes for their preparation |
| 06/23/1996 | CA2165603A1 3-alkoxybenzylpiperidine derivatives as melatonergic agents |
| 06/20/1996 | WO1996018649A1 Improved cyclic crf agonists |
| 06/20/1996 | WO1996018648A1 Superagonists and antagonists of h il-6, and 3d modelling method for their selection |
| 06/20/1996 | WO1996018641A1 Modulators of the function of fas/apo1 receptors |
| 06/20/1996 | WO1996018639A1 Novel protein tyrosine kinase, jak3 |
| 06/20/1996 | WO1996018636A1 3'-substituted nucleoside derivatives |
| 06/20/1996 | WO1996018626A1 Imidazole derivatives as protein kinase inhibitors in particular egf-r tyrosine kinase |
| 06/20/1996 | WO1996018418A1 Improved adenoviral vectors and producer cells |
| 06/20/1996 | WO1996018413A1 Carcinoma treatment |
| 06/20/1996 | WO1996018412A1 Chimeric cytokines and uses thereof |
| 06/20/1996 | WO1996018410A1 Agent for treating primary liver cancer and a method of treating primary liver cancer |
| 06/20/1996 | WO1996018409A1 In vivo activation of tumor-specific cytotoxic t cells |
| 06/20/1996 | WO1996018408A1 Human cancer inhibitory pentapeptide heterocyclic and halophenyl amides |
| 06/20/1996 | WO1996018407A1 Use of incense in the treatment of alzheimer's disease |
| 06/20/1996 | WO1996018404A1 Sphingosine, methylsphingosine and apoptosis |
| 06/20/1996 | WO1996018401A1 Method and composition for reducing tumor development with a combination of a taxane compound and a tellurium and/or selenium compound |
| 06/20/1996 | WO1996018392A1 Method and composition for reducing tumor development with a combination of platinum and tellurium or selenium compounds |
| 06/20/1996 | WO1996015234A3 Lipid-splitting enzyme |
| 06/20/1996 | DE4444288A1 Verwendung von Weihrauch zur Behandlung der Alzheimer-Krankheit Use of incense for treating Alzheimer's disease |
| 06/20/1996 | CA2207736A1 In vivo activation of tumor-specific cytotoxic t cells |
| 06/20/1996 | CA2207626A1 Novel protein tyrosine kinase, jak3 |
| 06/20/1996 | CA2207576A1 Improved cyclic crf agonists |
| 06/20/1996 | CA2207437A1 Use of incense in the treatment of alzheimer's disease |
| 06/20/1996 | CA2206890A1 Sphingosine, methylsphingosine and apoptosis |
| 06/20/1996 | CA2206683A1 Improved adenoviral vectors and producer cells |
| 06/20/1996 | CA2205572A1 Chimeric cytokines and uses thereof |
| 06/20/1996 | CA2177838A1 A methodology for selecting superagonists, antagonists and superantagonists of human interleukin-6 based on receptor complex three dimensional modelling |
| 06/20/1996 | CA2165374A1 Restricted 9-cis-retenoids |
| 06/19/1996 | EP0717041A1 Crystalline paclitaxel hydrates |
| 06/19/1996 | EP0717034A1 Vitamin D compounds and method of preparing these compounds |
| 06/19/1996 | EP0716701A1 Cloning of a member of the serine-threonine-kinase family |
| 06/19/1996 | EP0716660A1 MUTANTS OF THE Rb AND p53 GENES AND USES THEREOF |
| 06/19/1996 | EP0716614A1 Treatment of human tumors by genetic transformation of human tumor cells |